(Q37362620)

19 August 2017

1 reference

title

Therapeutic perspectives in bronchial vascular remodeling in COPD. (English)

1 reference

microvasculature remodeling

19 August 2017

main subject

1 reference

Andrea Zanini

1

1 reference

19 August 2017

Alfredo Chetta

series ordinal

2

1 reference

19 August 2017

Dario Olivieri

series ordinal

3

1 reference

19 August 2017

publication date

1 June 2008

1 reference

Therapeutic advances in respiratory disease

19 August 2017

published in

1 reference

19 August 2017

volume

2

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

179-187

1 reference

Kinase inhibitors and airway inflammation.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Transcription factors in airway diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Prospects for new drugs for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Small airway dimensions in smokers with obstruction to airflow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Angiogenesis in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Vascular remodelling and angiogenesis in asthma: morphological aspects and pharmacological modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Effect of an MMP-9/MMP-12 inhibitor on smoke-induced emphysema and airway remodelling in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Therapeutic inhibition of matrix metalloproteinases for the treatment of chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Molecular mechanisms in chronic obstructive pulmonary disease: potential targets for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Neovastat--a novel antiangiogenic drug for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Airway microvascular extravasation and luminal entry of plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Sorafenib and sunitinib in the treatment of advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF-1, FGF-2, and FGFR-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Effect of montelukast and fluticasone propionate on airway mucosal blood flow in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Vascularity in asthmatic airways: relation to inhaled steroid dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Vascular endothelial growth factor trap in non small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Cellular and structural bases of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Management of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Increased Airway Vascularity in Newly Diagnosed Asthma Using a High-magnification Bronchovideoscope

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

New perspectives on basic mechanisms in lung disease. 4. Why are the airways so vascular?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Airway vascular remodeling in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Repression of Inflammatory Gene Expression in Human Pulmonary Epithelial Cells by Small-Molecule I B Kinase Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

Increased activation of p38 MAPK in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808092339

21 January 2018

Identifiers

DOI

10.1177/1753465808092339

1 reference

19 August 2017

1 reference